Enhanced LPAR6 signalling promotes migration of prostate cancer cells and its overexpression is associated with squamous cell carcinomas of the lung, cervix, skin, urinary bladder, testis, head and neck [1]. The gene discussed is LPAR6; the disease is prostate carcinoma.